Fulminant malignant hyperthermia associated with ketoacidotic diabetic coma

Intensive Care Medicine

Volumn 22, Issue 8, 1996, Pages 809-812

  Wappler, F ^a   Roewer, N ^a   Kochling A ^a   Braune, H ^b   Reissinger, T ^b   Schulte Am Esch, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Abt für Anästhesiologie   (Germany)

Author keywords

Caffeine; Cresol; Diabetes; Halothane; Malignant hyperthermia; Stress

Indexed keywords

CRESOL; DANTROLENE; ELECTROLYTE; INSULIN;

ADULT; ARTICLE; CASE REPORT; DIABETIC COMA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEVER; HUMAN; KETOACIDOSIS; MALE; MALIGNANT HYPERTHERMIA; METABOLIC ACIDOSIS; MYALGIA;

EID: 0029952879     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709525     Document Type: Article

References (12)

1. Gronert GA, Antognini JF (1994) Malignant hyperthermia. In: Miller RD (ed) Anesthesia, 4th edn. Churchill Livingstone, New York Edinburgh London, pp 1075-1093
2. Hackl W, Winkler M, Mauritz W, Sporn P, Steinbereithner K (1991) Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. Br J Anaesth 66:138-140
3. Wingard DW (1980) A stressful situation. Anesth Analg 59:321-322
4. Moøller-Petersen J, Thorgaard Andersen P, Hjørne N, Ditzel J (1986) Non-traumatic rhabdomyolysis during diabetic ketoacidosis. Diabetologia 29:229-234
5. Wood MLB, Griffith DNW, Hooper RJL, Patterson DLH, Yudkin JS (1988) Fatal rhabdomyolysis associated with hyperosmolar diabetic decompensation. Diabetes Res 8:97-99
6. Smith RJ (1988) Preoperative assessment of risk factors. Br J Anaesth 60:317-319
7. Wappler F, Roewer N, Köchling A, Scholz J, Steinfath M, Schulte am Esch J (1996) In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles. Anesth Analg 82: 1230-1236
8. Galloway GJ, Denborough MA (1986) Suxamethonium chloride and malignant hyperpyrexia. Br J Anaesth 58: 447-450
9. 2+ release. Mol Pharmacol 44:1192-1201
10. Herrmann-Frank A, Richter M, Sarközi S, Mohr U, Lehmann-Horn F (1996) 4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta 1289:31-40
11. Campbell IT, Ellis FR, Evans RT (1981) Metabolic rate and blood hormone and metabolite levels of individuals susceptible to malignant hyperpyrexia at rest and in response to food and mild exercise. Anesthesiology 55:46-52
12. Campbell IT, Ellis FR, Evans RT, Mortimer MG (1983) Studies of body temperature, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand 27:349-355